The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10914 malaria professionals are enjoying the free benefits of MalariaWorld today

Falciparum

Atypical caseinolytic protease homolog from Plasmodium falciparum possesses unusual substrate preference and a functional nuclear localization signal

October 29, 2009 - 13:58 -- Ingeborg van Schayk
Author(s): 
Wenjie Lin, Maurice Chan & Tiow-Suan Sim
Reference: 
Parasitology Research, Volume 105, Number 6 / November, 2009 : 1715-1722, DOI 10.1007/s00436-009-1612-9

Although ATP-dependent caseinolytic protease (Clp) complexes are important for regulating the pathogenicity, survival, and development of many pathogens, their physiological roles in the pathogenicity of malarial parasites remain unknown. This study reports the cloning, authentication, and characterization of a putative Clp protease subunit from Plasmodium falciparum (PfClpP).

Phenotypic and transcriptomic analyses of Plasmodium falciparum protein kinase A catalytic subunit inhibition

October 29, 2009 - 13:51 -- Ingeborg van Schayk
Author(s): 
Nathalie Wurtz, Jérôme Desplans & Daniel Parzy
Reference: 
Parasitology Research, Volume 105, Number 6 / November, 2009 : 1691-1699, DOI 10.1007/s00436-009-1615-6

In this study, gene silencing with double-stranded RNA (dsRNA) and microarray techniques were used to study the biological function of the cAMP-dependent protein kinase catalytic subunit (PfPKAc) in the parasite erythrocytic life cycle.

Simultaneous transcription of duplicated var2csa gene copies in individual Plasmodium falciparum parasites

October 29, 2009 - 13:28 -- Ingeborg van Schayk
Author(s): 
Brolin KJ, Ribacke U, Nilsson S, Ankarklev J, Moll K, Wahlgren M, Chen Q
Reference: 
Genome Biology 2009, 10:R117 (22 October 2009)

Allelic discrimination assays have traditionally been applied to study zygosity in diploid genomes. The assays presented here are instead successfully applied to the identification and evaluation of transcriptional activity of duplicated genes in the haploid genome of the P. falciparum parasite.

Comparison of different methods for delayed post-mortem diagnosis of falciparum malaria

October 29, 2009 - 12:43 -- Ingeborg van Schayk
Tags: 
Author(s): 
Nicole Berens-Riha, Inga Sinicina, Erna Fleischmann, Thomas Loscher
Reference: 
Malaria Journal 2009, 8:244 (28 October 2009)

An interesting paper which addresses the issue of delayed post-mortem diagnosis of P. falciparum with ICT tests.

Medical Condition: 

Distillery: Therapeutic: Plasmepsin (Plasmodium falciparum)

October 25, 2009 - 17:01 -- Bart G.J. Knols
Author(s): 
-
Reference: 
Science-Business eXchange 2, (15 October 2009) doi:10.1038/scibx.2009.1508

In vitro studies identified a plasmepsin inhibitor that could aid in the development of new treatments for malaria. Further details on the research, next steps and licensing status are discussed in the article.

 

Special Focus Review: From the circumsporozoite protein to the RTS,S/AS candidate vaccine

October 25, 2009 - 16:43 -- Ingeborg van Schayk
Tags: 
Author(s): 
Joe Cohen, Victor Nussenzweig, Johan Vekemans and Amanda Leach
Reference: 
Human Vaccines, Volume 6, Issue 1, January 2010

The RTS,S/AS01E malaria vaccine candidate has recently entered phase 3 testing. Reaching this important milestone is the culmination of more than 20 years of research and development by GlaxoSmithKline and partners and collaborators. The vaccine has been developed to protect young children and infants living in sub-Saharan Africa against clinical and severe disease caused by Plasmodium falciparum infection.

Continent: 
Medical Condition: 
Medical Treatment: 

Special Focus Review: The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development

October 25, 2009 - 16:06 -- Ingeborg van Schayk
Author(s): 
Lars Hviid
Reference: 
Human Vaccines, Volume 6, Issue 1, January 2010

This review summarizes the evidence that VSAs are important targets of NAI, discusses why VSA-based vaccines might be feasible despite the extensive intra- and interclonal variation of VSAs, and how vaccines based on this type of antigens fit into the current global strategy to reduce, eliminate, and eventually eradicate the burden of malaria.

Technology: 
Medical Condition: 
Medical Treatment: 

Special Focus Review: The past decade in malaria synthetic peptide vaccine clinical trials

October 25, 2009 - 15:59 -- Ingeborg van Schayk
Author(s): 
Elizabeth Nardin
Reference: 
Human Vaccines, Volume 6, Issue 1, January 2010

Over the past  decade (2000 – 2009),  there have been nine clinical trials of synthetic malaria peptide vaccines designed to target the pre-erythrocytic and erythrocytic stages of the Plasmodium falciparum parasite. The results of these clinical trials, while encouraging, have emphasized the critical roles of immunological assays, in particular functional assays, for the evaluation of potential vaccine candidates.  Additional challenges include the need for potent adjuvants for the development of synthetic peptide vaccines that can effectively target multiple stages of the Plasmodium parasite.

Medical Condition: 
Medical Treatment: 

Research Brief: Disruption of lipid rafts by lidocaine inhibits erythrocyte invasion by Plasmodium falciparum

October 25, 2009 - 15:26 -- Ingeborg van Schayk
Author(s): 
Ichiro Koshino, Yuichi Takakuwa
Reference: 
Experimental Parasitology, Volume 123, Issue 4, December 2009, Pages 381-383, doi:10.1016/j.exppara.2009.08.019

Membrane lipid rafts have been implicated in erythrocyte invasion process by Plasmodium falciparum. In this study, we examined the effect of lidocaine, a local anesthetic, which disrupts lipid rafts reversibly without affecting membrane cholesterol content on parasite invasion. Our findings show that disruption of lipid rafts in the context of normal cholesterol content markedly inhibits parasite invasion and confirm an important role for lipid rafts in invasion of erythrocytes by P. falciparum.

Medical Condition: 
Medical Treatment: 

Mechanisms of Resistance: Plasmodium falciparum Drug Resistance in Madagascar: Facing the Spread of Unusual pfdhfr and pfmdr-1 Haplotypes and the Decrease of Dihydroartemisinin Susceptibility

October 25, 2009 - 15:02 -- Ingeborg van Schayk
Tags: 
Author(s): 
Valérie Andriantsoanirina et al.
Reference: 
Antimicrob. Agents Chemother. 2009 53: 4588-4597, doi:10.1128/AAC.00610-09

The aim of this study was to provide the first comprehensive spatiotemporal picture of Plasmodium falciparum resistance in various geographic areas in Madagascar. Additional data about the antimalarial resistance in the neighboring islands of the Comoros archipelago were also collected.

Continent: 

Pages

Subscribe to RSS - Falciparum